卓悦控股(00653.HK)主席遭副主席叶俊亨入禀追债 主席称申索款项毫无根据
卓悦控股(00653.HK)公布,於6月8日公司主席兼执行董事陈健文(被告)收到代表叶俊亨之律师於香港高等法院原讼法庭所出具关於针对被告的传讯令状。原告为公司的副主席兼执行董事。
根据传讯令状,原告主张被告归还7,500万元的款项,即被告於2019年2月至7月期间的一系列原告授予被告的贷款项下应付的尚未偿还款项或其他已持有及取得的款项。
陈健文发表声明指,叶俊亨入禀提出申索款项毫无根据,且没有理据支持。其正在就上述之申索寻求法律建议,为个人立场全力辩护,并保留一切法律权利向叶氏进行反索偿;就任何蓄意或恶意损害其声誉的行为,务必诉诸法律行动,追究到底。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.